Human bone marrow-derived MSCs spontaneously express specific Schwann cell markers.

Area of Science:

• Regenerative Medicine
• Cell Biology
• Neuroscience

Background:

• Schwann cells (SC) are crucial for peripheral nerve regeneration but are limited for clinical use.
• Mesenchymal stem cells (MSCs) are being investigated for cell-based therapies.
• Human bone marrow-derived MSCs (hBM-MSCs) are a potential source for SC-like cells.

Purpose of the Study:

• To evaluate the effectiveness of transdifferentiating hBM-MSCs into a SC lineage using an established induction protocol.
• To analyze the expression of key SC markers in undifferentiated and transdifferentiated hBM-MSCs.

Main Methods:

• Established homogenous hBM-MSC cultures (P3) conforming to ISCT minimal criteria.
• Applied induction media containing β-mercaptoethanol, retinoic acid, and growth factors.
• Utilized quantitative RT-PCR, flow cytometry, and immunocytochemistry to assess SC marker expression (S100, GFAP, MPZ, p75 NGFR).

Main Results:

• Spontaneous expression of SC markers was observed in undifferentiated hBM-MSCs.
• MPZ (myelin protein zero) mRNA was consistently detected pre- and post-transdifferentiation.
• Upregulation of NGF (nerve growth factor), MPB (myelin basic protein), GDNF (glial cell-derived neurotrophic factor), and p75 NGFR (p75 neurotrophic receptor) transcripts (>2-fold) post-transdifferentiation.

Conclusions:

• MSC transdifferentiation into SCs is a heterogeneous process with inter-donor variability.
• Relying on a single marker is insufficient to confirm SC fate.
• Revising MSC identification criteria and understanding subpopulation heterogeneity is crucial for optimizing SC transdifferentiation protocols.